These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Cocaine- and food-maintained responding under a multiple schedule in rhesus monkeys: environmental context and the effects of a dopamine antagonist. Nader MA; Sinnott RS; Mach RH; Morgan D Psychopharmacology (Berl); 2002 Oct; 163(3-4):292-301. PubMed ID: 12373430 [TBL] [Abstract][Full Text] [Related]
10. Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys. Negus SS; Gatch MB; Mello NK; Zhang X; Rice K J Pharmacol Exp Ther; 1998 Jul; 286(1):362-75. PubMed ID: 9655881 [TBL] [Abstract][Full Text] [Related]
11. Behavioral effects of cocaine: interactions with D1 dopaminergic antagonists and agonists in mice and squirrel monkeys. Katz JL; Kopajtic TA; Myers KA; Mitkus RJ; Chider M J Pharmacol Exp Ther; 1999 Oct; 291(1):265-79. PubMed ID: 10490913 [TBL] [Abstract][Full Text] [Related]
12. Effects of kappa opioid agonists on cocaine- and food-maintained responding by rhesus monkeys. Mello NK; Negus SS J Pharmacol Exp Ther; 1998 Aug; 286(2):812-24. PubMed ID: 9694938 [TBL] [Abstract][Full Text] [Related]
13. Effects of chronic administration of the D1 receptor partial agonist SKF 77434 on cocaine self-administration in rhesus monkeys. Mutschler NH; Bergman J Psychopharmacology (Berl); 2002 Apr; 160(4):362-70. PubMed ID: 11919663 [TBL] [Abstract][Full Text] [Related]
14. The self-administration of MK-801 can depend upon drug-reinforcement history, and its discriminative stimulus properties are phencyclidine-like in rhesus monkeys. Beardsley PM; Hayes BA; Balster RL J Pharmacol Exp Ther; 1990 Mar; 252(3):953-9. PubMed ID: 2181113 [TBL] [Abstract][Full Text] [Related]
15. Effects of dopamine D(1-like) and D(2-like) agonists in rats that self-administer cocaine. Caine SB; Negus SS; Mello NK; Bergman J J Pharmacol Exp Ther; 1999 Oct; 291(1):353-60. PubMed ID: 10490924 [TBL] [Abstract][Full Text] [Related]
16. Behavioral and neurochemical evaluation of phenylpropanolamine. Woolverton WL; Johanson CE; de la Garza R; Ellis S; Seiden LS; Schuster CR J Pharmacol Exp Ther; 1986 Jun; 237(3):926-30. PubMed ID: 3712285 [TBL] [Abstract][Full Text] [Related]
17. Effects of cocaine under concurrent fixed ratio schedules of food and IV drug availability: a novel choice procedure in monkeys. Paronis CA; Gasior M; Bergman J Psychopharmacology (Berl); 2002 Oct; 163(3-4):283-91. PubMed ID: 12373429 [TBL] [Abstract][Full Text] [Related]
18. Comparative behavioral pharmacology of cocaine and the selective dopamine uptake inhibitor RTI-113 in the squirrel monkey. Howell LL; Czoty PW; Kuhar MJ; Carrol FI J Pharmacol Exp Ther; 2000 Feb; 292(2):521-9. PubMed ID: 10640288 [TBL] [Abstract][Full Text] [Related]
19. Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo. Tolliver BK; Newman AH; Katz JL; Ho LB; Fox LM; Hsu K; Berger SP J Pharmacol Exp Ther; 1999 Apr; 289(1):110-22. PubMed ID: 10086994 [TBL] [Abstract][Full Text] [Related]
20. Enhanced sensitivity to the behavioral effects of cocaine after chronic administration of D2-selective dopamine antagonists in the squirrel monkey. Howell LL; Byrd LD J Pharmacol Exp Ther; 1992 Sep; 262(3):907-15. PubMed ID: 1388204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]